Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from Clover Biopharmaceuticals Ltd. ( (HK:2197) ).
Clover Biopharmaceuticals Ltd. announced the postponement of its board meeting originally scheduled for March 24, 2025, to March 31, 2025. The delay is due to the need for additional time to finalize the company’s annual results for the year ended December 31, 2024, which are crucial for evaluating the payment of a final dividend.
More about Clover Biopharmaceuticals Ltd.
Clover Biopharmaceuticals Ltd. is a company incorporated in the Cayman Islands, operating in the biopharmaceutical industry. The company focuses on developing innovative therapies and products, with a market emphasis on addressing significant medical needs.
YTD Price Performance: 34.85%
Average Trading Volume: 1,618,911
Technical Sentiment Signal: Hold
Current Market Cap: HK$421.5M
For a thorough assessment of 2197 stock, go to TipRanks’ Stock Analysis page.